Literature DB >> 21887844

Clinical heterogeneity in patients with early-stage Parkinson's disease: a cluster analysis.

Ping Liu1, Tao Feng, Yong-jun Wang, Xuan Zhang, Biao Chen.   

Abstract

The aim of this study was to investigate the clinical heterogeneity of Parkinson's disease (PD) among a cohort of Chinese patients in early stages. Clinical data on demographics, motor variables, motor phenotypes, disease progression, global cognitive function, depression, apathy, sleep quality, constipation, fatigue, and L-dopa complications were collected from 138 Chinese PD subjects in early stages (Hoehn and Yahr stages 1-3). The PD subject subtypes were classified using k-means cluster analysis according to the clinical data from five- to three-cluster consecutively. Kappa statistical analysis was performed to evaluate the consistency among different subtype solutions. The cluster analysis indicated four main subtypes: the non-tremor dominant subtype (NTD, n=28, 20.3%), rapid disease progression subtype (RDP, n=7, 5.1%), young-onset subtype (YO, n=50, 36.2%), and tremor dominant subtype (TD, n=53, 38.4%). Overall, 78.3% (108/138) of subjects were always classified between the same three groups (52 always in TD, 7 in RDP, and 49 in NTD), and 98.6% (136/138) between five- and four-cluster solutions. However, subjects classified as NTD in the four-cluster analysis were dispersed into different subtypes in the three-cluster analysis, with low concordance between four- and three-cluster solutions (kappa value=-0.139, P=0.001). This study defines clinical heterogeneity of PD patients in early stages using a data-driven approach. The subtypes generated by the four-cluster solution appear to exhibit ideal internal cohesion and external isolation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21887844      PMCID: PMC3167902          DOI: 10.1631/jzus.B1100069

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  28 in total

1.  A rating scale for depression.

Authors:  M HAMILTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1960-02       Impact factor: 10.154

Review 2.  Non-motor symptoms of Parkinson's disease: diagnosis and management.

Authors:  K Ray Chaudhuri; Daniel G Healy; Anthony H V Schapira
Journal:  Lancet Neurol       Date:  2006-03       Impact factor: 44.182

3.  Clinical heterogeneity in newly diagnosed Parkinson's disease.

Authors:  Bart Post; Johannes D Speelman; Rob J de Haan
Journal:  J Neurol       Date:  2008-03-17       Impact factor: 4.849

Review 4.  Functional bowel disorders and functional abdominal pain.

Authors:  W G Thompson; G F Longstreth; D A Drossman; K W Heaton; E J Irvine; S A Müller-Lissner
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

5.  Risk factors in young-onset Parkinson's disease.

Authors:  L I Golbe
Journal:  Neurology       Date:  1993-09       Impact factor: 9.910

6.  Laterality, region, and type of motor dysfunction correlate with cognitive impairment in Parkinson's disease.

Authors:  Lindsy N Williams; Paul Seignourel; Gregory P Crucian; Michael S Okun; Ramon L Rodriguez; Frank M Skidmore; Paul S Foster; Charles E Jacobson; Janet Romrell; Dawn Bowers; Hubert H Fernandez
Journal:  Mov Disord       Date:  2007-01       Impact factor: 10.338

7.  UPDRS activity of daily living score as a marker of Parkinson's disease progression.

Authors:  Madaline B Harrison; Scott A Wylie; Robert C Frysinger; James T Patrie; Diane S Huss; Lillian J Currie; G Frederick Wooten
Journal:  Mov Disord       Date:  2009-01-30       Impact factor: 10.338

Review 8.  Early Parkinson's disease and non-motor issues.

Authors:  K Ray Chaudhuri; Yogini Naidu
Journal:  J Neurol       Date:  2008-09       Impact factor: 4.849

9.  A clinicopathologic study of 100 cases of Parkinson's disease.

Authors:  A J Hughes; S E Daniel; S Blankson; A J Lees
Journal:  Arch Neurol       Date:  1993-02

10.  Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach.

Authors:  S J G Lewis; T Foltynie; A D Blackwell; T W Robbins; A M Owen; R A Barker
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-03       Impact factor: 10.154

View more
  11 in total

1.  Citric acid reduces the decline in P300 amplitude induced by acute alcohol consumption in healthy adults.

Authors:  Wei-xing Chen; Chuan-qin Xu; Shao-hua Chen; Gen-yun Xu; Huai-zhuang Ye
Journal:  J Zhejiang Univ Sci B       Date:  2012-05       Impact factor: 3.066

2.  Inverse associations of outdoor activity and vitamin D intake with the risk of Parkinson's disease.

Authors:  Dan Zhu; Gui-you Liu; Zheng Lv; Shi-rong Wen; Sheng Bi; Wei-zhi Wang
Journal:  J Zhejiang Univ Sci B       Date:  2014-10       Impact factor: 3.066

3.  Gait and balance in Parkinson's disease subtypes: objective measures and classification considerations.

Authors:  Talia Herman; Aner Weiss; Marina Brozgol; Nir Giladi; Jeffrey M Hausdorff
Journal:  J Neurol       Date:  2014-09-24       Impact factor: 4.849

4.  Common variant rs356182 near SNCA defines a Parkinson's disease endophenotype.

Authors:  Christine A Cooper; Nimansha Jain; Michael D Gallagher; Daniel Weintraub; Sharon X Xie; Yosef Berlyand; Alberto J Espay; Joseph Quinn; Karen L Edwards; Thomas Montine; Vivianna M Van Deerlin; John Trojanowski; Cyrus P Zabetian; Alice S Chen-Plotkin
Journal:  Ann Clin Transl Neurol       Date:  2016-11-25       Impact factor: 4.511

5.  Developing and validating Parkinson's disease subtypes and their motor and cognitive progression.

Authors:  Donald G Grosset; Michele T M Hu; Michael Lawton; Yoav Ben-Shlomo; Margaret T May; Fahd Baig; Thomas R Barber; Johannes C Klein; Diane M A Swallow; Naveed Malek; Katherine A Grosset; Nin Bajaj; Roger A Barker; Nigel Williams; David J Burn; Thomas Foltynie; Huw R Morris; Nicholas W Wood
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-07-25       Impact factor: 10.154

Review 6.  Computational systems biology approaches for Parkinson's disease.

Authors:  Enrico Glaab
Journal:  Cell Tissue Res       Date:  2017-11-29       Impact factor: 5.249

7.  Parkinson's Disease Subtypes in the Oxford Parkinson Disease Centre (OPDC) Discovery Cohort.

Authors:  Michael Lawton; Fahd Baig; Michal Rolinski; Claudio Ruffman; Kannan Nithi; Margaret T May; Yoav Ben-Shlomo; Michele T M Hu
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

8.  What to Do When K-Means Clustering Fails: A Simple yet Principled Alternative Algorithm.

Authors:  Yordan P Raykov; Alexis Boukouvalas; Fahd Baig; Max A Little
Journal:  PLoS One       Date:  2016-09-26       Impact factor: 3.240

9.  Acupuncture Modulates the Cerebello-Thalamo-Cortical Circuit and Cognitive Brain Regions in Patients of Parkinson's Disease With Tremor.

Authors:  Zhe Li; Jun Chen; Jianbo Cheng; Sicong Huang; Yingyu Hu; Yijuan Wu; Guihua Li; Bo Liu; Xian Liu; Wenyuan Guo; Shuxuan Huang; Miaomiao Zhou; Xiang Chen; Yousheng Xiao; Chaojun Chen; Junbin Chen; Xiaodong Luo; Pingyi Xu
Journal:  Front Aging Neurosci       Date:  2018-07-05       Impact factor: 5.750

Review 10.  Is It Possible to Conduct a Multi-Arm Multi-Stage Platform Trial in Parkinson's Disease: Lessons Learned from Other Neurodegenerative Disorders and Cancer.

Authors:  Marie-Louise Zeissler; Vivien Li; Mahesh K B Parmar; Camille Buchholz Carroll
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.